Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002012383-26-003898·First Tracks Biotherapeutics, Inc.
Schedule 13G ownership disclosure
First Tracks Biotherapeutics, Inc.
Common Stock · CUSIP: 337185102
Event date: 2026-09-30
- Filing-level shares
- 2,558,473
- Percent of class
- 7.2%
- BlackRock, Inc.
Shares: 2,558,473 · Class: 7.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-26-003898
- Form type
- SCHEDULE 13G/A
- Filer
- First Tracks Biotherapeutics, Inc.
- CIK
- CIK 2091349
- Filed
- Oct 27, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership